Aridis Pharmaceuticals Inc (ARDS)

$0.00 0.00 (-84.62%)
Market Cap 69,000.00
Revenue (ttm) 3.09M
Net Income (ttm) -30.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -982.85%
Debt to Equity Ratio 0.00
Volume 2,400
Avg Vol 23,572
Day's Range N/A - N/A
Shares Out 53.32M
Stochastic %K 8%
Beta 39.09
Analysts Strong Buy
Price Target $2.00

Company Profile

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin, as well as developing AR-301 as an adjunctive therapy with SOC antibiotics to treat hospital acquir...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 385 1742
Fax: 408 356 9548
Address:
983 University Avenue, Building B, Los Gatos, United States
Shanenobody
Shanenobody Sep. 15 at 7:32 PM
$ARDS 250,000 shares traded today at .0013?
3 · Reply
Flibble
Flibble Sep. 15 at 5:20 AM
$ARDS Friday was another 100k volume day. Weird.
1 · Reply
Shanenobody
Shanenobody Sep. 8 at 11:30 PM
$ARDS What's going on with this stock? Today's volume is 102,250. I don't recall this kind of volume since they went on the expert market. I'm not saying it hasn't happened, I just don't recall it happening. To make this a little more puzzling, the price has gone up twice in the last week as well.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Sep. 2 at 5:13 AM
$ARDS 12%??? That's it folks. Put a fork in it. Game over man. Game over. Done. Finished. We LOST all our money invested in this stock. No future for it left. Too bad. I was hoping for so much more. I gambled and I LOST it all.
1 · Reply
Bigos
Bigos Aug. 22 at 4:14 PM
$ARDS Per the article, in the Phase III clinical trial the cure rate only increased by 12%, mostly in elderly adults. 12% --- no wonder no big pharma wants to buy this company, and Vu has gone silent.
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Aug. 21 at 2:17 PM
$ARDS Since dumbass can't use Google translate https://news-gbimonthly-com.translate.goog/tw/audiovisual/show.php?num=78887&page=2&kind=11&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp
2 · Reply
Phaaisatroll
Phaaisatroll Aug. 10 at 9:08 AM
$ARDS a bit from the conference where Vu went recently. https://reurl.cc/bmlzel
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Aug. 7 at 2:57 AM
$ARDS I could easily drive over to the company's office to see if it's dark, but I enjoy watching @Phaaisatroll slowly lose his mind...
3 · Reply
ReturnOfEsquire
ReturnOfEsquire Aug. 5 at 5:48 PM
$ARDS Is it true Vu Troung translates to "So long, suckers!"?
2 · Reply
Phaaisatroll
Phaaisatroll Jul. 27 at 10:14 PM
$ARDS Vu Truong was at a conference in Taipei. Hopefully this doesn't mean that he already left the country.
3 · Reply
Latest News on ARDS
No data available.
Shanenobody
Shanenobody Sep. 15 at 7:32 PM
$ARDS 250,000 shares traded today at .0013?
3 · Reply
Flibble
Flibble Sep. 15 at 5:20 AM
$ARDS Friday was another 100k volume day. Weird.
1 · Reply
Shanenobody
Shanenobody Sep. 8 at 11:30 PM
$ARDS What's going on with this stock? Today's volume is 102,250. I don't recall this kind of volume since they went on the expert market. I'm not saying it hasn't happened, I just don't recall it happening. To make this a little more puzzling, the price has gone up twice in the last week as well.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Sep. 2 at 5:13 AM
$ARDS 12%??? That's it folks. Put a fork in it. Game over man. Game over. Done. Finished. We LOST all our money invested in this stock. No future for it left. Too bad. I was hoping for so much more. I gambled and I LOST it all.
1 · Reply
Bigos
Bigos Aug. 22 at 4:14 PM
$ARDS Per the article, in the Phase III clinical trial the cure rate only increased by 12%, mostly in elderly adults. 12% --- no wonder no big pharma wants to buy this company, and Vu has gone silent.
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Aug. 21 at 2:17 PM
$ARDS Since dumbass can't use Google translate https://news-gbimonthly-com.translate.goog/tw/audiovisual/show.php?num=78887&page=2&kind=11&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp
2 · Reply
Phaaisatroll
Phaaisatroll Aug. 10 at 9:08 AM
$ARDS a bit from the conference where Vu went recently. https://reurl.cc/bmlzel
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Aug. 7 at 2:57 AM
$ARDS I could easily drive over to the company's office to see if it's dark, but I enjoy watching @Phaaisatroll slowly lose his mind...
3 · Reply
ReturnOfEsquire
ReturnOfEsquire Aug. 5 at 5:48 PM
$ARDS Is it true Vu Troung translates to "So long, suckers!"?
2 · Reply
Phaaisatroll
Phaaisatroll Jul. 27 at 10:14 PM
$ARDS Vu Truong was at a conference in Taipei. Hopefully this doesn't mean that he already left the country.
3 · Reply
ReturnOfEsquire
ReturnOfEsquire Jul. 11 at 12:25 AM
$ARDS No buyout yet? Next month? Next year? Next never?
1 · Reply
Shanenobody
Shanenobody Jun. 30 at 8:55 PM
$ARDS 41,000 shares traded today? What's up with that?
0 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Jun. 27 at 1:36 PM
$ARDS Would you classify this stock as a ZOMBIE company? Looks like it to me.
1 · Reply
xersdave
xersdave Jun. 19 at 1:25 PM
$ARDS Selling for a tax loss sometime in October. Thx for nothing Vu. Rather than sell the whole company your stubbornness allowed you to go under. We, the shareholders thank you so very much. Adios and good riddance.
1 · Reply
xersdave
xersdave Jun. 16 at 3:40 PM
$ARDS
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Jun. 13 at 3:15 AM
$ARDS Lesson here is words are worthless. You can't believe a word these fuckers (directors) say, and definitely ignore any douchbag who claims to have inside information.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr May. 20 at 3:30 PM
$ARDS When it comes down to it, I lost everything I invested in this stock. I suppose if false hope was not spoon fed to me, I would have sold earlier. Limited my losses. I am not an insider. I think Vu really screwed us. Should have known not to trust the guy with his lack of transparency. He left us all in the dark and closed shop. Turned off the lights and left us sitting in the dark talking amongst ourselves. I know nothing about backroom deals going on. I like to believe that there is some sliver of hope as remote as that sounds for this company. Not false or fake made up hope stories but real hope. How do you feel? You paid a lot to get here.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire May. 13 at 9:00 PM
$ARDS Buyout yet? No? I'll check back next month.
4 · Reply
Phaaisatroll
Phaaisatroll May. 8 at 10:16 AM
$ARDS for the people who still didn't see the news. Aridis is still alive and trying to finalize the 2 deals. If that's successful then things could be good and if its not successful then not good. https://www.aridispharma.com/wp-content/uploads/2025/04/Aridis-PR-Corporate-Update-Web-Apr2025_-003.pdf
1 · Reply
awfullyeducated
awfullyeducated May. 5 at 9:27 PM
$ARDS Yes I'll have a write-off in ARDS myself! Their approach to move away from traditional antibiotics into a new technology made sense to me. And they got organizations to pay for some of their earlier work, they were better then at getting funding EXAMPLE: Efficiently obtained funding for trials - example - by the Cystic Fibrosis Foundation for $7.5 million.
0 · Reply
Shanenobody
Shanenobody May. 5 at 8:06 PM
$ARDS 19,000 shares traded today. Hmmm.
1 · Reply
BostonDave
BostonDave May. 5 at 1:00 PM
$ARDS They will screw the shareholders, hand the company over to Streeterville to survive, and we'll all have a tax deduction.
1 · Reply